Trials / Unknown
UnknownNCT02582710
Impact of an Optimized Formulation of Omega 3 on the Composition of Atheromatous Plaques in Patients Requiring Carotid Endarterectomy
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 96 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 30 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Determining whether treatment with an optimized formulation of omega 3 for 6 weeks causes a 40% decrease in the average concentration of total microparticles (MPs) in the atheromatous plaque.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | VASCAZEN | 6 weeks treatment with an optimized formulation of omega 3 before the carotid endarterectomy |
| DIETARY_SUPPLEMENT | PLACEBO | 6 weeks treatment with a placebo before the carotid endarterectomy |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2018-02-01
- Completion
- 2018-02-01
- First posted
- 2015-10-21
- Last updated
- 2015-10-21
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02582710. Inclusion in this directory is not an endorsement.